From: Evaluation of Different Combined Regimens in the Treatment of Cholinergic Urticaria
Variable | Â | Group A | Group B | Group C | P |
---|---|---|---|---|---|
First | No signs and symptoms | Â | Â | Â | 0.0001 |
visit |    n (%) | 3 (3.3) | 34 (44.2) | 55 (67.1) |  |
 |    Eosinophil % | 7 | 5 | 5 |  |
 | Signs and symptoms |  |  |  | 0.01 |
 |    n (%) | 89 (96.7) | 43 (55.8) | 27 (32.9) |  |
 |    Eosinophil % | 7 | 6 | 6 |  |
Second | No signs and symptoms | Â | Â | Â | 0.01 |
visit |    n (%) | 20 (21.7) | 53 (68.8) | 64 (78) |  |
 |    Eosinophil % | 5 | 4 | 4 |  |
 | Signs and symptoms |  |  |  | 0.01 |
 |    n (%) | 72 (78.3) | 24 (31.2) | 18 (22) |  |
 |    Eosinophil % | 7 | 6 | 6 |  |
Third | No signs and symptoms |  |  |  |    > 0.05 |
visit |    n (%) | 25 (27.2) | 60 (77.9) | 65 (79.3) |  |
 |    Eosinophil % | 4 | 4 | 4 |  |
 | Signs and symptoms |  |  |  | 0.01 |
 |    n (%) | 67 (72.8) | 17 (22.1) | 17 (20.7) |  |
 |    Eosinophil % | 6 | 6 | 5 |  |
Fourth | No signs and symptoms | Â | Â | Â | 0.01 |
visit |    n (%) | 28 (30.4) | 64 (83.1) | 70 (85.4) |  |
 |    Eosinophil % | 4 | 4 | 3 |  |
 | Signs and symptoms |  |  |  | 0.01 |
 |    n (%) | 64 (69.6) | 13 (16.9) | 12 (14.6) |  |
 |    Eosinophil % | 6 | 6 | 5 |  |